rx 821002 has been researched along with dextroamphetamine in 3 studies
| Studies (rx 821002) | Trials (rx 821002) | Recent Studies (post-2010) (rx 821002) | Studies (dextroamphetamine) | Trials (dextroamphetamine) | Recent Studies (post-2010) (dextroamphetamine) |
|---|---|---|---|---|---|
| 317 | 0 | 45 | 7,044 | 697 | 660 |
| Protein | Taxonomy | rx 821002 (IC50) | dextroamphetamine (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.631 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.2884 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heal, DJ; Hughes, ZA; Stanford, SC; Wortley, KE | 1 |
| Hudson, AL; Hume, SP; Lalies, MD; Nutt, DJ; Robinson, ES; Tyacke, RJ | 1 |
| Schmidt, WJ; Srinivasan, J | 1 |
3 other study(ies) available for rx 821002 and dextroamphetamine
| Article | Year |
|---|---|
Comparison of changes in the extracellular concentration of noradrenaline in rat frontal cortex induced by sibutramine or d-amphetamine: modulation by alpha2-adrenoceptors.
Topics: Adrenergic alpha-Antagonists; Animals; Appetite Depressants; Cerebral Cortex; Cyclobutanes; Dextroamphetamine; Idazoxan; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2 | 1999 |
Estimation of endogenous noradrenaline release in rat brain in vivo using [3H]RX 821002.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Binding, Competitive; Brain; Dextroamphetamine; Idazoxan; Imidazoles; Male; Microdialysis; Monoamine Oxidase Inhibitors; Norepinephrine; Radioligand Assay; Rats; Rats, Wistar; Selegiline; Time Factors; Tissue Distribution; Tritium | 2005 |
Serotonergic influence on the potentiation of D-amphetamine and apomorphine-induced rotational behavior by the alpha2-adrenoceptor antagonist 2-methoxy idazoxan in hemiparkinsonian rats.
Topics: Adrenergic Agents; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Dextroamphetamine; Drug Synergism; Idazoxan; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Serotonin; Sympatholytics | 2005 |